Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q2 2018 · 10-Q
Revenue$3.36B$3.36B+9.0% vs Q2 2017 Net Income$866.60M$866.60M+0.4% vs Q2 2017 EPS Diluted$4.18$4.18+2.7% vs Q2 2017 Gross Profit$2,935,500,000+8.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,099,300,000−6.0% Free Cash Flowderived$912,500,000−6.1% Margins · derivedGross margin87.5%−0.6 pt vs Q2 2017
Operating margin36.1%−2.9 pt vs Q2 2017
Net margin25.8%−2.2 pt vs Q2 2017
ended Jun 30, 2018 · filed Jul 24, 2018 · 24 d after period end